levetiracetam 100 mg/ml oral solution
rosemont pharmaceuticals ltd - levetiracetam - oral solution - 100 mg/ml
paracetamol 120mg/5ml oral suspension
rosemont pharmaceuticals limited rosemont house, yorkdale industrial park, braithwaite street, leeds ls11 9xe, united kingdom - paracetamol - oral suspension - paracetamol 120 mg/5ml - analgesics
amlodipine 1mg/ml oral solution
rosemont pharmaceuticals ltd - amlodipine - oral solution - 1 milligram(s)/millilitre - dihydropyridine derivatives; amlodipine
amlodipine 2mg/ml oral solution
rosemont pharmaceuticals ltd - amlodipine - oral solution - 2 milligram(s)/millilitre - dihydropyridine derivatives; amlodipine
dexsol 2 mg/ 5 ml oral solution
rosemont pharmaceuticals ltd - dexamethasone sodium phosphate - oral solution - 2 mg/5ml - glucocorticoids; dexamethasone
paracetamol adult 500mg/5ml oral suspension
rosemont pharmaceuticals ltd - paracetamol - oral suspension - 500 mg/5ml - anilides; paracetamol
ramipril 2.5mg/5ml oral solution
rosemont pharmaceuticals ltd - ramipril - oral solution - 2.5 mg/5ml - ace inhibitors, plain; ramipril
simvastatin 40 mg/5ml oral suspension
rosemont pharmaceuticals ltd - simvastatin - oral suspension - 40 mg/5ml - hmg coa reductase inhibitors
simvastatin 20 mg/5ml oral suspension
rosemont pharmaceuticals ltd - simvastatin - oral suspension - 20 mg/5ml - hmg coa reductase inhibitors
perizam 1mg/ml oral suspension
rosemont pharmaceuticals ltd - clobazam - oral suspension - 1 mg/ml - anxiolytics - it indicated in adults for the short-term symptomatic treatment (2-4 weeks) only of anxiety that is severe, disabling or subjecting the individual to unacceptable distress. in treatment of anxiety states associated with affected disorders, must only be used in conjunction with adequate treatments for the underlying disorder. in patients with schizophrenic or other psychotic illnesses, use of benzodiazepines is recommended only for short term symptomatic management of hyperarousal and agitation. benzodiazepines do not possess antipsychotic properties. it may be used as adjunctive therapy in epilepsy in adults or children over 6, if standard treatment with one or more anticonvulsants has failed.